Patents by Inventor John Dumas
John Dumas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210085870Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: ApplicationFiled: November 20, 2020Publication date: March 25, 2021Applicant: MONARCH MEDICAL TECHNOLOGIES, LLCInventors: TIMOTHY L. RUCHTI, WILLIAM PATRICK BURGESS, JOHN DUMAS, III, RONALD LISIECKI, CAROL DIAN MARTIN, LAURA SANTANA, JOHN HARRISON THORNLEY, JOANNE MARIE WATT
-
Patent number: 10842935Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: GrantFiled: July 30, 2018Date of Patent: November 24, 2020Assignee: Monarch Medical Technologies, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Publication number: 20180333535Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: ApplicationFiled: July 30, 2018Publication date: November 22, 2018Applicant: Monarch Medical Technologies, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Patent number: 10046781Abstract: A wheelbarrow for carrying materials is described herein, and may include a main frame having first and second spaced-apart elongate longitudinal arms and a support structure configured to engage the ground when the wheelbarrow is in a stationary position, a load carrying container for receiving a load therein, the load carrying container being mounted to and supported by the main frame and configured for supporting a load, an axle mounted to the main frame and below the container, and a ground engaging wheel rotatably mounted on the axle for moving the wheelbarrow in a mobile position. A hollow interior of the load carrying container may have an upper region and a lower region, the upper region located above the ground engaging wheel and extending along a substantial portion of a width of the container.Type: GrantFiled: May 21, 2015Date of Patent: August 14, 2018Assignee: ERGO MATE PTY LTDInventors: Philip John Dumas, Benjamin Mark Green
-
Patent number: 10046113Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: GrantFiled: December 21, 2012Date of Patent: August 14, 2018Assignee: Monarch Medical Technologies, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Publication number: 20170165425Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: ApplicationFiled: December 21, 2012Publication date: June 15, 2017Applicant: EndoTool, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Publication number: 20150329131Abstract: A wheelbarrow for carrying materials is described herein, and may include a main frame having first and second spaced-apart elongate longitudinal arms and a support structure configured to engage the ground when the wheelbarrow is in a stationary position, a load carrying container for receiving a load therein, the load carrying container being mounted to and supported by the main frame and configured for supporting a load, an axle mounted to the main frame and below the container, and a ground engaging wheel rotatably mounted on the axle for moving the wheelbarrow in a mobile position. A hollow interior of the load carrying container may have an upper region and a lower region, the upper region located above the ground engaging wheel and extending along a substantial portion of a width of the container.Type: ApplicationFiled: May 21, 2015Publication date: November 19, 2015Inventors: Philip John Dumas, Benjamin Mark Green
-
Publication number: 20070048785Abstract: Anti-IL-13 antibodies, crystals of anti-IL-13 antibodies, IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13 polypeptide/anti-IL-13 antibody complexes, IL-13R?1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13R?1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, and related methods and software systems are disclosed.Type: ApplicationFiled: June 9, 2005Publication date: March 1, 2007Inventors: Laura Lin, Kevin Parris, Amy Sze Tam, Xiang-Yang Tan, Tania Shane, John Dumas, James Wilhelm, Mark Stahl, Lidia Mosyak, Zhixiang Hu
-
Patent number: 6569925Abstract: The present invention is directed to a an accelerator-gel additive used to deliver an accelerator such as sulfur, into a system for the production of polymer modified asphalt, vulcanized rubber or similar system. Unlike conventional methods of delivering accelerator into the system, the accelerator-gel additive suspends the accelerator in a gel system thereby preventing the sedimentation of the accelerator during processing. As a result, the polymer and asphalt are processed at lower temperature reducing the production of toxic and flammable gases such as hydrogen sulfide.Type: GrantFiled: August 9, 2002Date of Patent: May 27, 2003Assignee: Ergon, IncorporatedInventors: Gaylon L. Baumgardner, Martin R. Burrow, John Dumas, Andrew Menapace, James Smith
-
Patent number: 6569351Abstract: The present invention is directed to a an accelerator-gel additive used to deliver an accelerator such as sulfur, into a system for the production of polymer modified asphalt, vulcanized rubber or similar system. Unlike conventional methods of delivering accelerator into the system, the accelerator-gel additive suspends the accelerator in a gel system thereby preventing the sedimentation of the accelerator during processing. As a result, the polymer and asphalt are processed at lower temperature reducing the production of toxic and flammable gases such as hydrogen sulfide.Type: GrantFiled: March 14, 2000Date of Patent: May 27, 2003Assignee: Ergon, Inc.Inventors: Gaylon L. Baumgardner, Martin R. Burrow, John Dumas, Andrew Menapace, James Smith
-
Publication number: 20030004234Abstract: The present invention is directed to a an accelerator-gel additive used to deliver an accelerator such as sulfur, into a system for the production of polymer modified asphalt, vulcanized rubber or similar system. Unlike conventional methods of delivering accelerator into the system, the accelerator-gel additive suspends the accelerator in a gel system thereby preventing the sedimentation of the accelerator during processing. As a result, the polymer and asphalt are processed at lower temperature reducing the production of toxic and flammable gases such as hydrogen sulfide.Type: ApplicationFiled: August 9, 2002Publication date: January 2, 2003Inventors: Gaylon L. Baumgardner, Martin R. Burrow, John Dumas, Andrew Menapace, James Smith
-
Patent number: D811680Type: GrantFiled: March 23, 2015Date of Patent: February 27, 2018Assignee: ERGO MATE PTY LTDInventors: Philip John Dumas, Benjamin Mark Green